« Back to Record
Citation APA

Freyer, G., Rougier, P., Bugat, R., Droz, J.-P., Marty, M., Bleiberg, H., Mignard, D., Awad, L., Herait, P., Culine, S., & Trillet-Lenoir, V. (2000). Prognostic factors for tumour response, progression-free survival and toxicity in metastatic colorectal cancer patients given irinotecan (CPT-11) as second-line chemotherapy after 5FU failure. British Journal of Cancer, 83(4), 431-437.


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/90304

Freyer, G., Rougier, P., Bugat, R., Droz, J.-P., Marty, M., Bleiberg, H., Mignard, D., Awad, L., Herait, P., Culine, S., & Trillet-Lenoir, V. (2000). Prognostic factors for tumour response, progression-free survival and toxicity in metastatic colorectal cancer patients given irinotecan (CPT-11) as second-line chemotherapy after 5FU failure. British Journal of Cancer, 83(4), 431-437.